14th March 2018 - Upperton Pharma Solutions to offer cGMP spray drying and clinical trials manufacturing serviceUpperton Pharma Solutions is pleased to announce that the company has relocated to larger, self-contained facilities at Highfields Science Park, adjacent to the University of Nottingham. The move to new premises underlines the company’s rapid expansion and will enable it to develop its own cGMP manufacturing capabilities for early phase clinical trials.
The 15,000 square foot facility will house all of the company’s R&D team, as well as its fast-growing Quality Assurance and Manufacturing departments. Within the building is a clean room suite suitable for cGMP manufacture, and a pilot plant for non-GMP intermediate scale manufacturing. Upperton plans to have an MHRA licence for clinical trials manufacturing by Q3 of 2018.
The relocation and expansion will allow the company to offer a full integrated pharmaceutical development service, from early feasibility studies through to cGMP manufacture to support clinical trials. The extended range of capabilities includes:
- cGMP manufacturing for clinical trials, release testing and QP release
- Range of additional powder handling and filling capabilities
- Enhanced dosage form development service
- Expanded analytical service
In the coming weeks we will be sharing more news about our move and the new services we will be offering our customers.
The conference will focus on how nano and materials technologies can strengthen competitiveness across all European industries.
Upperton Limited will be attending the Making Pharmaceuticals Exhibition & Conference at the Ricoh Arena, Coventry from 25-26 April 2017. We would be delighted to hear from any delegates who are interested in learning more about our services and capabilities. Find out more from the conference website
A new 4M8-Trix ProCepT spray dryer has been delivered and is now being commissioned at Upperton. It brings the number of spray dryers that we have in our laboratory and pilot plant to eleven.
A new automated Q5000 SA Dynamic Vapour Sorption analyser (TA Instruments) has been installed in Upperton’s analytical laboratory.
Nottingham, UK – 18th November, 2016 —Upperton is pleased to announce that it has acquired a Quantos MicroDosing unit that can be used to precisely fill a range of dosage forms including capsules, and devices for inhaled and nasal drug delivery. The new Quantos system is capable of dosing to an accuracy of ± 0.5mg, independent of substance characteristics, operator or environmental conditions. The system learns the characteristics of a product, with an RFID chip present in the dosing head storing all the key information on the substance used, including batch number and powder characteristics. Actual fill weights of each individual capsule or device are captured electronically and can be printed if required.
Nottingham, UK – 10th October, 2016 — Upperton is pleased to announce that it is to sponsor the 6th Annual MiBio Conference at Magdalene College, Cambridge (9th November 2016)
Nottingham, UK – 28th May, 2016 — Upperton has entered into a partnership with Quotient Clinical, the Translational Pharmaceutics® Company, to deliver a complete spray drying service for pharmaceutical and biotechnology companies seeking to develop spray dried formulations for clinical use. The partnership will see Upperton working with Quotient Clinical to supply GMP manufacturing services at Quotient within the MediCity life science innovation hub in Nottingham, UK.